Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases

Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases

US Patent 7868012 · Granted Jan 11, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridin-3-yl derivatives2025
Pharmaceutical combination comprising a selective S1P1 receptor agonist2025
(2-acetamidyl)thio-beta-D-galactopyranoside derivatives2025
(Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives2025
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their 2025
Alpha-D-galactopyranoside derivatives2025
Spiro derivatives of Alpha-D-galactopyranosides2025
Hydroxyheterocycloalkane-carbamoyl derivatives2025
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan2025
2-hydroxycycloalkane-1-carbamoyl2025
Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives2025
Combination of a 4-pyrimidinesulfamide derivative with an SGLT-2 inhibitor for t2024